RCM
KNTE
RA Capital Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,264,144
| Closed | -$26.7M | – | 61 |
|
|
2023
Q1 | $26.7M | Hold |
4,264,144
| – | – | 0.6% | 43 |
|
|
2022
Q4 | $26M | Hold |
4,264,144
| – | – | 0.53% | 42 |
|
|
2022
Q3 | $51M | Hold |
4,264,144
| – | – | 1.09% | 32 |
|
|
2022
Q2 | $53.8M | Hold |
4,264,144
| – | – | 1.43% | 22 |
|
|
2022
Q1 | $48M | Buy |
4,264,144
+671,092
| +19% | +$7.56M | 1.05% | 30 |
|
|
2021
Q4 | $63.7M | Hold |
3,593,052
| – | – | 1.12% | 26 |
|
|
2021
Q3 | $82.7M | Hold |
3,593,052
| – | – | 1.15% | 28 |
|
|
2021
Q2 | $83.6M | Hold |
3,593,052
| – | – | 1.34% | 22 |
|
|
2021
Q1 | $112M | Hold |
3,593,052
| – | – | 1.69% | 16 |
|
|
2020
Q4 | $143M | Buy |
+3,593,052
| New | +$143M | 2% | 10 |
|